Perrigo - Best Pharma Stocks of 2007

Company: Perrigo
Starting stock price: $17.61
Ending stock price: $35.01
Percent Change: 98.81%

Details: Perrigo develops, manufactures and distributes OTC and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients and consumer products. In December 2007 Perrigo won FDA approval for an OTC, generic heartburn treatment the company will market in partnership with Dexcel Pharma.

More News:
Perrigo gets OK for generic heartburn drug. Report
Dexcel gets right to sell copycat Prilosec. Report

Perrigo - Best Pharma Stocks of 2007
Read more on

Suggested Articles

After more than 10 years as partners, Sanofi and Regeneron are splitting up their deal to comarket PCSK9 med Praluent and immunology drug Kevzara.

Fujifilm has completed the first manufacturing facility in Japan to make drug-delivering liposomes to use for cancer fighting drugs it is developing.

J&J chief Alex Gorsky has assured plenty of critics that its talc products are safe, but he's not interested in explaining to Congress.